These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26054374)

  • 1. Immunochemotherapy in Waldenström macroglobulinemia - still the backbone of treatment.
    Buske C; Seymour JF
    Leuk Lymphoma; 2015; 56(9):2489-90. PubMed ID: 26054374
    [No Abstract]   [Full Text] [Related]  

  • 2. Proteasome inhibitors in Waldenström macroglobulinemia.
    Treon SP
    Blood; 2013 Nov; 122(19):3243-4. PubMed ID: 24203925
    [No Abstract]   [Full Text] [Related]  

  • 3. There's life in the old dog yet: immunochemotherapy in Waldenström's macroglobulinemia.
    Kastritis E; Buske C
    Leukemia; 2024 Jun; 38(6):1435-1436. PubMed ID: 38454119
    [No Abstract]   [Full Text] [Related]  

  • 4. A 44-Year-Old Man with Waldenstrom Macroglobulinemia and Bilateral Maxillary Sinusitis.
    Trianto HB; Wardhani SO
    Acta Med Indones; 2016 Jul; 48(3):221-227. PubMed ID: 27840358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Waldenström macroglobulinemia: my way.
    Gertz M
    Leuk Lymphoma; 2013 Mar; 54(3):464-71. PubMed ID: 22860921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete remission of Waldenström macroglobulinemia with azacitidine and rituximab.
    Weiss L; Melchardt T; Neureiter D; Kemmerling R; Moshir S; Pleyer L; Greil R; Egle A
    J Clin Oncol; 2011 Aug; 29(24):e696-8. PubMed ID: 21730268
    [No Abstract]   [Full Text] [Related]  

  • 7. Waldenström macroglobulinemia: a review of therapy.
    Gertz MA
    Am J Hematol; 2005 Jun; 79(2):147-57. PubMed ID: 15929102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolution of Waldenström's macroglubulinemia related isolated neutropenia by immunochemotherapy.
    van Gelder M; van Marion A; Goossens V; Bommer M; Leblond V
    Am J Hematol; 2011 Apr; 86(4):380-2. PubMed ID: 21442645
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnosis and treatment of Waldenstrom's macroglobulinemia: 4 case reports].
    Lu SF; Chen XW; Lin TB
    Zhonghua Nei Ke Za Zhi; 1985 Jun; 24(6):358-9, 382-3. PubMed ID: 3926417
    [No Abstract]   [Full Text] [Related]  

  • 10. Rituximab-induced life-threatening coagulopathy occurring in a patient with Waldenström macroglobulinemia treated with fludarabine, cyclophosphamide, and rituximab combination.
    Pilorge S; Park S; Dreyfus F; Bouscary D; Tamburini J
    Leuk Lymphoma; 2010 Dec; 51(12):2288-90. PubMed ID: 20929331
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic diarrhea: A case of Waldenström macroglobulinemia.
    Amado Garzón SB; Villanueva Ortega MM; Botero Bahamón JD
    Rev Gastroenterol Mex (Engl Ed); 2018; 83(4):467-469. PubMed ID: 29463427
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclophosphamide, bortezomib, and dexamethasone combination in waldenstrom macroglobulinemia.
    Leblebjian H; Noonan K; Paba-Prada C; Treon SP; Castillo JJ; Ghobrial IM
    Am J Hematol; 2015 Jun; 90(6):E122-3. PubMed ID: 25703132
    [No Abstract]   [Full Text] [Related]  

  • 13. AA amyloidosis associated with macroglobulinemia.
    Tatara R; Nagai T; Kobayashi H; Hatano K; Suzuki T; Muroi K; Ozawa K
    Int J Hematol; 2010 Nov; 92(4):675-7. PubMed ID: 20953745
    [No Abstract]   [Full Text] [Related]  

  • 14. Waldenstrom macroglobulinemia presenting with pancreatic mass: a case report and review of literature.
    Nayak HK; Kar P; Bagchi A; Kapoor N; Kapahtia S; Sonika U; Kumar N; Kumar S
    JOP; 2013 Jan; 14(1):92-5. PubMed ID: 23306344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bendamustine plus rituximab in newly-diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO).
    Laribi K; Poulain S; Willems L; Merabet F; Le Calloch R; Eveillard JR; Herbaux C; Roos-Weil D; Chaoui D; Roussel X; Tricot S; Dupuis J; Dartigeas C; Bareau B; Bene MC; Baugier de Materre A; Leblond V
    Br J Haematol; 2019 Jul; 186(1):146-149. PubMed ID: 30548257
    [No Abstract]   [Full Text] [Related]  

  • 16. Cutaneous Infiltration due to Waldenström Macroglobulinemia.
    Oscoz-Jaime S; Agulló-Pérez AD; Llanos-Chavarri C; Yanguas-Bayona JI
    Actas Dermosifiliogr (Engl Ed); 2018; 109(1):75-78. PubMed ID: 28784233
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase 2 study of ofatumumab, fludarabine and cyclophosphamide in relapsed/refractory Waldenström's macroglobulinemia.
    Gavriatopoulou M; Kastritis E; Kyrtsonis MC; Vassilakopoulos TP; Roussou M; Fotiou D; Migkou M; Mpakiri M; Tasidou A; Terpos E; Dimopoulos MA
    Leuk Lymphoma; 2017 Jun; 58(6):1506-1508. PubMed ID: 27724158
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of serum immunoglobulin free light chain in response and progression in waldenstrom macroglobulinemia.
    Leleu X; Xie W; Bagshaw M; Banwait R; Leduc R; Roper N; Weller E; Ghobrial IM
    Clin Cancer Res; 2011 May; 17(9):3013-8. PubMed ID: 21415221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current treatment options for Waldenström macroglobulinemia.
    Vijay A; Gertz MA
    Clin Lymphoma Myeloma; 2008 Aug; 8(4):219-29. PubMed ID: 18765309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative outcomes of immunochemotherapy regimens in Waldenström macroglobulinaemia.
    Olszewski AJ; Chen C; Gutman R; Treon SP; Castillo JJ
    Br J Haematol; 2017 Oct; 179(1):106-115. PubMed ID: 28677830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.